Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

HCV antibody screening over time.

Absolute HCV antibody screens, birth cohort (BC) vs. non-BC over time January 2017 to October 2021 for all MedStar outpatient sites. The first arrow (left) indicates the approximate re-implementation of the electronic health record (EHR) alert for the birth cohort in September 2018. The second arrow (right) indicates the approximate implementation of the universal screening EHR alert on May 28th, 2020.

More »

Fig 1 Expand

Table 1.

Absolute numbers and characteristics of HCV screened individuals from 1/2017-10/2021.

More »

Table 1 Expand

Fig 2.

Screening rate and total outpatient visits 2020.

Screening rate per 1,000 outpatient visits and total outpatient visits, both screened and unscreened, between January 1st, 2020 to October 31st, 2020. The arrow indicates the approximate implementation of the universal screening electronic health record alert on May 28th, 2020.

More »

Fig 2 Expand

Table 2.

Characteristics and percentages of all individuals (screened and unscreened) and all screened individuals seen in the MedStar outpatient setting for 10 months between 1/1/2020-10/31/2020.

More »

Table 2 Expand

Table 3.

Multivariable mixed effects logistic regression models for pre-post 6/1/2020 (model one) and by month 1/2020-10/2020 (model two).

More »

Table 3 Expand